A new publication using Attana Technology from National University of Singapore examining the neutralization capacity of human IgG antibodies agsinst different mutations of the SARS-CoV-2
During the pandemic it has been observed that individuals react very differently to be infected by the virus and to the vaccination. A few individuals obtain very strong protection against the wild type (the original Wuhan) and the mutated variants, whereas others obtain less good protection. This paper in Nature Communications focus on characterizing the neutralization capacity (protection) of antibodies from convalescent COVID-19 individuals against SARS-CoV-2 virus. Using Attana technology, kinetic characterization of the antibody-spike